Alpha IVF Group BhdXKLS:0303 +2.08%50 EBITDA Margin % is 42.95% as of Feb. 2026, which is 5% below its 10-year median of 45.00. GuruFocus rates XKLS:0303 with a GF Score™ of 50/100. Among 664 Healthcare Providers & Services companies, Alpha IVF Group Bhd ranks better than 96.54% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Alpha IVF Group Bhd's EBITDA for the
three
months ended in Feb. 2026 was RM20.2 Mil. Alpha IVF Group Bhd's Revenue for the
three
months ended in Feb. 2026 was RM47.1 Mil. Therefore, Alpha IVF Group Bhd's EBITDA margin for the quarter that ended in Feb. 2026 was 42.95%.
Alpha IVF Group Bhd (XKLS:0303) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Alpha IVF Group Bhd EBITDA Margin % Related Terms
Alpha IVF Group Bhd EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Alpha IVF Group Bhd's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0303 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Alpha IVF Group Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha IVF Group Bhd EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alpha IVF Group Bhd's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Alpha IVF Group Bhd's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha IVF Group Bhd (XKLS:0303) has a EBITDA Margin % of 42.95% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Alpha IVF Group Bhd and its competitors. This is near median its historical median of 45.00. Over the past decade, Alpha IVF Group Bhd's EBITDA Margin % has ranged from 18.93 to 54.72. According to the industry distribution chart, Alpha IVF Group Bhd ranks #23 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 3.5%.
Is Alpha IVF Group Bhd's EBITDA Margin % too high?
Alpha IVF Group Bhd's current EBITDA Margin % of 42.95% is near median its 10-year median of 45.00. Over the past 10 years, this metric has ranged from a low of 18.93 to a high of 54.72. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Alpha IVF Group Bhd's value of 42.95% is 320.7% above this industry median. Based on the distribution chart, Alpha IVF Group Bhd ranks #23 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alpha IVF Group Bhd has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Alpha IVF Group Bhd ranks #23 out of 664 companies for EBITDA Margin %. This places Alpha IVF Group Bhd in the top 4% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Alpha IVF Group Bhd's value of 42.95% is 320.7% above this benchmark. Historically, Alpha IVF Group Bhd's own EBITDA Margin % has ranged from 18.93 to 54.72 over the past decade. While the company's 10-year median is 45.00 vs. the industry median of 10.21, Alpha IVF Group Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha IVF Group Bhd's current EBITDA Margin % of 42.95% is 320.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Alpha IVF Group Bhd and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha IVF Group Bhd's current EBITDA Margin % is 42.95%, which is near median its own 10-year median of 45.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current EBITDA Margin % of 42.95%. The current EBITDA Margin % is 42.95%, which is near median its 10-year median of 45.00 and 320.7% above the Healthcare Providers & Services industry median of 10.21. Alpha IVF Group Bhd's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current EBITDA Margin % is 42.95% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
50GF Score
Get the complete analysis for XKLS:0303
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0303 has been successfully added to your 
